Interactions between Hepatic Stellate Cells and the Immune System
The DOI matches its Crossref record.
Abstract
Stellate cells and immune cells are both active participants in the pathogenesis of liver disease. Interactions between these two populations are important determinants of disease outcome. Kupffer cells, neutrophils, and lymphocytes all have the potential to influence stellate cells. They produce a host of humoral mediators, including oxidants, nitric oxide, cytokines, eicosanoids, and proteinases, which can affect stellate cell proliferation, gene expression, and contractility. One important feature of stellate cell-immune cell interactions is that they are bidirectional. Not only do stellate cells receive signals from leukocytes, but they also elaborate signals that target leukocytes. Specifically, stellate cells can promote leukocyte chemotaxis and adherence, and they may also influence leukocyte activation by producing regulatory cytokines. Studies in culture provide an important background for understanding the effects of specific mediators on stellate cells and immune cells. Experiments in vivo offer an important adjunct, but often lead to confounding effects that limit interpretation. Both types of studies are required to develop a better understanding of the complex interplay between stellate cells and leukocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interplay between HSCs and hepatic immune cells, long recognized as a key feature of the hepatic injury response, has emerged as an especially important determinant of NASH pathogenesis (5, 7, 8).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [7]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 225
Immunohistochemical Studies of Stellate Cells in Experimental Cholestasis in Newborn and Adult Rats
Gibelli, N. E. M., Tannuri, U., & de Mello, E. S. (2008) · Clinics · doi:10.1590/s1807-59322008000500019 · Cited by 27
Gorrell, M. D., Wang, X. M., Levy, M. T., Kable, E., Marinos, G., Cox, G. C., & McCaughan, G. W. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47920-6_28 · Cited by 27
Massey, V. L., Cabezas, J., & Bataller, R. A. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1605371 · Cited by 26
Kong, X. Y., Nesset, C. K., Daμμe, M., Løberg, E. M., Lübke, T., Mæhlen, J., Andersson, K. B., Lorenzo, P. I., Roos, N., Thoresen, G. H., et al. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.014050 · Cited by 26
Kubo, N., Saito, R., Hamano, K., Nagasawa, M., Aoki, F., Takei, I., Umezawa, K., Kuwano, H., & Kojima, I. (2013) · Liver International · doi:10.1111/liv.12328 · Cited by 25
Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation
Osawa, Y., Seki, E., Adachi, M., Taura, K., Kodama, Y., Siegmund, S., Schwabe, R. F., & Brenner, D. A. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01346.x · Cited by 25
Biomimetic nanoparticles for targeted therapy of liver disease
Vijayan, V., Unagolla, J. M., Panchal, D., Okoh, J. E., Menon, S. S., & Menon, J. U. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00044k · Cited by 24
Migita, K., Maeda, Y., Abiru, S., Nakamura, M., Komori, A., Yokoyama, T., Takii, Y., Mori, T., Yatsuhashi, H., Eguchi, K., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.10.003 · Cited by 24
Abdel‐Salam, O. M. E., Oraby, F., & Hassan, N. S. (2007) · Acta Biologica Hungarica · doi:10.1556/abiol.58.2007.4.8 · Cited by 23
Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis
Li, H., Ding, P., Peng, B., & Ming, Y. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.04.007 · Cited by 23
The role of methyl-CpG binding protein 2 in liver fibrosis
Bian, E., Huang, C., Wang, H., Chen, X., Tao, H., Zhang, L., Lv, X., & Li, J. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.008 · Cited by 23
Wu, M., Liao, C., Du, W.-Y., Kao, T. C., Su, K., Lin, Y., Chang, C., & Fan, C. (2007) · Acta Tropica · doi:10.1016/j.actatropica.2007.11.005 · Cited by 22
Mohammadian, Z., Eidi, A., Mortazavi, P., Tavangar, S. M., & Asghari, A. (2015) · Polish Journal of Pathology · doi:10.5114/pjp.2015.51153 · Cited by 22
Schäck, L. M., Büettner, M., Wirth, A., Neunaber, C., Krettek, C., Hoffmann, A., & Noack, S. (2015) · Stem Cells International · doi:10.1155/2016/1319578 · Cited by 22
Guo, L., Enzan, H., Hayashi, Y., Miyazaki, E., Jin, Y., Toi, M., Kuroda, N., & Hiroi, M. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.07.006 · Cited by 22
Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2
Zakaria, S., & El‐Sisi, A. E. (2016) · Journal of Immunotoxicology · doi:10.3109/1547691x.2015.1128022 · Cited by 21
Leicester, K. L., Olynyk, J. K., Brunt, E. M., Britton, R. S., & Bacon, B. R. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01255.x · Cited by 21
Regulating Hepatic Inflammation: Pathogen–Associated Molecular Patterns Take Their Toll
Iredale, J. P. (2003) · Hepatology · doi:10.1053/jhep.2003.50224 · Cited by 21
Fan, C., Hung, C., Lin, Y., Li, M.-H., & Su, K. (2004) · Parasitology Research · doi:10.1007/s00436-004-1233-2 · Cited by 20
CD14‐positive hepatic monocytes/macrophages increase in hereditary hemochromatosis
Leicester, K. L., Olynyk, J. K., Brunt, E. M., Britton, R. S., & Bacon, B. R. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0943.x · Cited by 20
Apoptosis and fibrosis in non-alcoholic fatty liver disease.
Canbay, A. E., Kip, S. N., Kahraman, A., Gieseler, R. K. H., Naycı, A., & Gerken, G. (2005) · The Turkish Journal of Gastroenterology · Cited by 19
Extrahepatic factors in hepatic immune regulation
Zhang, S., Lu, S., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941721 · Cited by 18
A humanized mouse model of liver fibrosis following expansion of transplanted hepatic stellate cells
Benten, D., Kluwe, J., Wirth, J. W., Thiele, N. D., Follenzi, A., Bhargava, K. K., Palestro, C. J., Koepke, M., Tjandra, R., Volz, T., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0010-7 · Cited by 17
Lmo4‐resistin signaling contributes to adipose tissue‐liver crosstalk upon weight cycling
Sun, Y., Geng, M., Yuan, Y., Guo, P., Chen, Y., Yang, D. L., Petersen, R. B., Huang, K., & Zheng, L. (2020) · The FASEB Journal · doi:10.1096/fj.201902708r · Cited by 17
Jeong, E. J., Kim, N.-H., Heo, J., Lee, K. Y., Rho, J., Kim, Y. C., & Sung, S. H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00583 · Cited by 17
Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis
Brandão, D. F., Ramalho, F. S., Martinelli, A. D. L. C., Zucoloto, S., & Ramalho, L. N. Z. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.08.002 · Cited by 17
Hong, Y., Han, Y., Wang, Y., Gao, J., Li, Y., Liu, Q., & Lun-zhu, X. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.07.010 · Cited by 16
The impact of emricasan on chronic liver diseases: current data
Lekakis, V., & Cholongitas, Ε. (2022) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-021-01585-2 · Cited by 16
Gil, M. N., Choi, D. R., Yu, K. S., Jeong, J. H., Bak, D., Kim, D. K., Lee, N., Lee, J., Jeong, Y., Na, C.-S., et al. (2016) · Anatomy & Cell Biology · doi:10.5115/acb.2016.49.3.189 · Cited by 15
Mechanisms of liver fibrosis: New insights into an old problem
Wells, R. G. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.10.003 · Cited by 15
Nanogene editing drug delivery systems in the treatment of liver fibrosis
Wang, Q., Jia, S., Wang, Z., Chen, H., Jiang, X., Li, Y., & Ji, P. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1418786 · Cited by 13
Fibrogénesis hepática: fisiopatología
Òdena, G., & Bataller, R. A. (2012) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(12)70043-2 · Cited by 13
Jameel, N. M., Thirunavukkarasu, C., Murase, N., Cascio, M., Prelich, J. G., Yang, S., Harvey, S. A. K., & Gandhi, C. R. (2010) · Liver Transplantation · doi:10.1002/lt.22172 · Cited by 13
Song, Y., Chen, X., Kong, X., Liu, N., Li, W., Wu, X., Lin, J., & Jin, Y. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.744 · Cited by 12
Relationship between Kuppfer cells, inflammation, and fibrosis in chronic hepatitis B and C.
Stănculeţ, N., Grigoraş, A., Avădănei, E. R., Floarea-Strat, A., Amălinei, C., & Căruntu, I.-D. (2013) · The Medical-Surgical Journal · Cited by 11
Laursen, T. L., Villesen, I. F., Leeming, D. J., Karsdal, M. A., Sølund, C. S., Tarp, B., Kristensen, L. H., Holmboe, C. H., Leutscher, P. D. C., Laursen, A. L., et al. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13416 · Cited by 11
Kashimura, M. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13363 · Cited by 10
Using Microfluidic Hepatic Spheroid Cultures to Assess Liver Toxicity of T-2 Mycotoxin
Taroncher, M., Gonzalez‐Suarez, A. M., Gwon, K., Romero, S., Reyes-Figueroa, A. D., Rodríguez-Carrasco, Y., Ruiz, M.-J., Stybayeva, G., Revzin, A., & de Hoyos‐Vega, J. M. (2024) · Cells · doi:10.3390/cells13110900 · Cited by 10
Wang, F., Gan, J., Li, R., Yang, R., Mao, X., Liu, S., Chen, Y., Duan, Z., & Li, J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304185 · Cited by 10
Tanabe, K. K., Zahrieh, D. M., Strand, C. A., Hoshida, Y., Flotte, T. J., Della’Zanna, G., Umar, A., Chavin, K. D., Cleary, S. P., Kubota, N., et al. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.01.009 · Cited by 9
Toll-like receptor signaling in the liver
Seki, E., Brenner, D. A., & Schwabe, R. F. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7441-1_7 · Cited by 9
Chen, Y.-R., Chang, K.-T., Tsai, M., Lee, C.-H., Huang, K., Cheng, H., Ho, Y., Chen, J.-C., Yang, H., & Weng, C.-F. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.04.006 · Cited by 8
Signal Transduction in Alcohol‐Related Diseases
Apte, M. V., Zima, T., Dooley, S., Siegmund, S., Pandol, S. J., & Singer, M. V. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000171893.14163.07 · Cited by 8
Zoheir, K. M. A., Amara, A. A. A. F., Ahmad, S. F., Mohammad, M. A., Ashour, A. E., Harisa, G. I., & Abd‐Allah, A. R. A. (2014) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2014.11.001 · Cited by 8
HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways
Sommerhalder, C., Cummins, C. B., Wang, X., Ramdas, D., Lopez, O. N., Gu, Y., Zhou, J., & Radhakrishnan, R. S. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2020.12.045 · Cited by 7
Insights into the pathogenesis of NAFLD: The role of metabolic and pro-inflammatory mediators
Xirouchakis, E., Manousou, P., Tsartsali, L., Georgopoulos, S., & Burroughs, A. K. (2009) · Annals of Gastroenterology · Cited by 7
Stem Cells and Progenitors in Liver Development
Muench, M. O. (2012) · Colloquium Series on Stem Cell Biology · doi:10.4199/c00070ed1v01y201212scb003 · Cited by 6
Ehnert, S., Knobeloch, D., Blankenstein, A., Müller, A., Böcker, U., Gillen, S., Friess, H., Thasler, W. E., Dooley, S., & Nussler, A. K. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01140.x · Cited by 6
Bockx, I., Elst, I. V., Roskams, T., & Cassiman, D. M. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02229.x · Cited by 6
Hirway, S. U., Nairon, K. G., Skardal, A., & Weinberg, S. H. (2024) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-024-00831-0 · Cited by 5
Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?
Zhongqi, F., Xiaodong, S., Chen, Y., & Lv, G. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666181114112431 · Cited by 5
Hepatic Stellate Cells Induce Immunotolerance of Islet Allografts
Zhang, Z., Zhou, Z., Song, K. B., Kim, S.-C., & Zhou, G.-W. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.03.009 · Cited by 5
El-Bassiouni, N. E., Elmessery, L. O., Zayed, R. A., Metwally, O. B., Zahran, M. Y., Mahmoud, O., Ibrahim, R. A., & Bassiouny, A. E. E. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1757-x · Cited by 4
Husić-Selimović, A., Sofić, A., Huskić, J., & Bulja, A. (2016) · Medical Archives · doi:10.5455/medarh.2016.70.92-96 · Cited by 4
Chu, D., Li, C., Wu, Q., & Shen, J. (2008) · Frontiers of Medicine · doi:10.1007/s11684-008-0029-7 · Cited by 4
Effect of ribozyme against transforming growth factorβ1 on biological character of activated HSCs
Song, Y., Zhou, X. M., Xue, X. N., Liu, N. Z., Tian, D. A., Kong, X., Wu, X., Lin, J. S., & Jin, Y. (2005) · IUBMB Life · doi:10.1080/15216540400024470 · Cited by 4
Cell Biology of NASH: Fibrosis and Cell Proliferation
Leclercq, I. A., & Horsmans, Y. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch12 · Cited by 4
Hussain, Z. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100563 · Cited by 3
The Immunopathogenesis of Cirrhosis
Gao, B., Friedman, S. L., & Mehal, W. Z. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_28 · Cited by 4
Cellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight
Parida, G. R., Pattnaik, G., & Behera, A. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01066 · Cited by 3
Assessment of Immunity Status in Patients with Pancreatic Cancer
Geetha, A., Jeyachristy, S. A., & Surendran, R. (2006) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.39.18 · Cited by 3
Establishment and characterization of an immortalized rat hepatic stellate cell line.
Li, T., Leng, X.-S., Zhu, J., & Wang, F. (2015) · PubMed · Cited by 3
Relations entre foie et immunité
Duclos‐Vallée, J., Ballot, É., & Johanet, C. (2003) · EMC - Hépatologie · doi:10.1016/s1155-1976(03)00068-8 · Cited by 3
The Transplantation of Pancreatic Islets to Portal Vein: The Influence on Liver Tissue
Vojtíšková, A., Fábryová, E., Berková, Z., Koblas, T., Girman, P., & Kříž, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031419 · Cited by 2
Регенерация печени млекопитающих: межклеточные взаимодействия
Ельчанинов, А. В., & Fatkhudinov, T. (2020) · Наука eBooks · doi:10.7868/9785020407770 · Cited by 2
Hepatic Stellate Cells and Hepatocyte Survival
Gandhi, C. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00013-0 · Cited by 2
The Liver and the Immune System
Knolle, P. A. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50014-0 · Cited by 2
Relations entre foie et immunité
Ballot, E., Beleoken, E., Mustafa, M. Z., Johanet, C., & Duclos‐Vallée, J. (2012) · EMC - Hépatologie · doi:10.1016/s1155-1976(12)54243-9 · Cited by 2
Gibelli, N. E. M. (2003) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2003.tde-11112005-112052 · Cited by 2
The study of troglitazone liver toxicity via in vitro and in silico approaches
Nuamah, M. F. (2022) · Nottingham ePrints (University of Nottingham) · Cited by 2
Sharma, P., Ghufran, S. M., Roy, B., Ghose, S., & Biswas, S. (2026) · FEBS Letters · doi:10.1002/1873-3468.70310 · Cited by 2
Elbakidze, G. M., & Medentsev, A. G. (2013) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v68i2.549 · Cited by 1
Husić-Selimović, A., Vukobrat-Bijedić, Z., Huskić, J., & Bijedić, N. (2012) · Medical Archives · doi:10.5455/medarh.2012.66.300-303 · Cited by 1
Hepatic Sinusoidal Cells and Liver-Associated Lymphocytes
Gardner, C. R., Laskin, J. D., & Laskin, D. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65377-1 · Cited by 1
Knolle, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00009-7 · Cited by 2
Singer, P. D. M. D. H. C. M. M. V., & Teyssen, P. D. M. S. (2005) · Springer eBooks · doi:10.1007/3-540-26446-9_20 · Cited by 1
Huang, J., Zhang, X., Su, L., Liu, M., Xu, M. T., Zhuang, B., Liu, B., Huang, T., Hu, H., Xie, X., et al. (2024) · Journal of Ultrasound in Medicine · doi:10.1002/jum.16597 · Cited by 1
The hepatic stellate cell in sight: targeting antiproliferative drugs to the fibrotic liver
Greupink, A. H. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Pipitone, R. M. (2016) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 1
Fowell, A. J. (2010) · ePrints Soton (University of Southampton)
Efeito do Ácido Gálico sobre a fibrogênese hepática murina
Figueiredo, S. S. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2012.tde-15052012-120349
Addressing liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells
Adrian, J. E. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Abdelall, G. M. (2015) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6750
Hepatic stellate cell – vitamin A-rich cells
Bennaser, S., & Bird, N. C. (2013) · Hamdan Medical Journal · doi:10.7707/hmj.v6i2.200
The end of the needle is in sight
Griffiths, P. D. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.413
Angiotensin Converting Enzyme in the Pathophysiology of Liver Fibrosis
Wei, Y. H. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-4483-6_8
Characterization of the role of CD14 in human and animal liver diseases
Leicester, K. L. (2004) · UWA Profiles and Research Repository (UWA)
Responses of mouse macrophages to oxidative stress
Connor, A. J. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3hm577w
Adhesion and invasion studies of uveal melanoma
Woodward, J. K. L. (2002) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Podstawy etiopatogenezy procesu włóknienia wątroby
Gutkowski, K. (2012) · European Journal of Clinical and Experimental Medicine
State-of-the-Art Lecture: Mechanisms of liver fibrosis — targets for therapy
Gordon‐Walker, T. T., Pellicoro, A., & Iredale, J. P. (2009) · Springer eBooks · doi:10.1007/978-90-481-2759-7_15
Johnson, A. R. (2014) · Figshare
Vreden, W. N., & Peterhänsel, C. (2008) · RWTH Publications (RWTH Aachen)
Can Proteomic Profiling Identify Biomarkers and/or Therapeutic Targets for Liver Fibrosis?
Katrinli, Ş., Doğanay, H. L., Özdil, K., & Doğanay, G. D. (2017) · InTech eBooks · doi:10.5772/65608
Effect of Curcumin and Gliotoxin on Rat Liver Myofibroblast Culture
Shafigullina, A. K., Mijanović, O., Prottoy, R. A., Zhuravleva, M. N., Gomzikova, M. O., Gumerova, A. A., Rizvanov, A. A., & Kiyasov, A. P. (2017) · BioNanoScience · doi:10.1007/s12668-017-0494-z
Regulation of rat SMAD1 gene expression
Sun, Y. (2006) · Mspace (University of Manitoba)
Rolle von CMKLR1 und dessen Liganden bei der nicht-alkoholischen Fettlebererkrankung
Pohl, R. (2018) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.36958
Impact of Different Sources of Infection on Therapy Response in Chronic Hepatitis C
Husić-Selimović, A., Sofić, A., Jahić, E., Prohić, D., & Merhemić, Z. (2018) · Medical Archives · doi:10.5455/medarh.2018.72.182-186
Ambiente e Genetica: due attori nello sviluppo e progressione del danno epatico
Marroncini, G. (2018) · Florence Research (University of Florence)
Metadata
- Authors
- Maher, J. J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Maher, Jacquelyn J.
- ORCID
- Maher, Jacquelyn J.
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 21
- Issue
- 03
- Pages
- 417-426
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2087877540
- Cited by
- 198
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 10 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 13 · 2012: 10
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k02aa000215-04, 5r01aa007810-12)
- National Institute on Alcohol Abuse and Alcoholism (AA07810, AA-00215)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK026743)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- hepatic stellate cells, Kupffer cells, neutrophils, lymphocytes, cytokines, nitric oxide, eicosanoids, proteolytic enzymes, stellate cell proliferation, leukocyte chemotaxis, leukocyte activation, liver disease pathogenesis
- MeSH terms
- Cell Adhesion, Cell Communication, Chemotaxis, Humans, Immune System, Kupffer Cells, Leukocytes, Liver, Liver Cirrhosis, Neutrophils, Signal Transduction, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.